42 Bio, LLC   ​​​​ © 2018 All rights reserved

About 42 Bio

42 Bio is a new spin-off company developing and commercializing biomedical technologies from our laboratories at the University of Florida.
 
These novel technologies combine biomaterials, magnetic nanotechnologies, and growth factors for applications in laboratory research/analysis,  tissue engineering and regenerative medicine.
 
42 Bio has an expanding patent portfolio available through UF.

42Bio "Bios"

             ​​​​ JON DOBSON                              PETER MCFETRIDGE                     BLANKA SHARMA
              Co-founder                                           Co-founder                                      Co-founder

Jon Dobson has a B.Sc. and M.Sc. from the University of Florida and a PhD from the Swiss Federal Institute of Technology (ETH-Zurich). He is currently UF Foundation Professor and J Crayton Pruitt Family Professor of Biomedical Engineering and Biomaterials and Associate Director of the Institute for Cell & Tissue Science & Engineering at UF. He also enjoys a nice brown ale or stout, though is not really an IPA fan.

Pete McFetridge is a fun-loving, Bar-B-Q-ing New Zelander with a fondness for DIY and IPA. Oh, and he also has a PhD in Chemical Engineering from Bath University in the United Kingdom and is Assocaite Professor of Biomedical Engineering at UF. He has pioneered novel growth factor technologies and bioreactor designs  for tissue engineering and regenerative medicine.

Blanka Sharma has a PhD from Johns Hopkins in Biomedical Engineering and did her postdoctoral work at Cleveland Clinic. She is Assistant Professor of Biomedical Engineering at UF. Blanka's research focuses on biomaterials for regenerative medicine. She is very polite and pleasant and much easier to get along with than either Pete or Jon.

             ​​​​  JERRY CHANG
                  Advisor 

Jerry Chang has more than 20 years of experience in biotech development and commercialization of with key roles in operations, product development, quality assurance and regulatory affairs. His career includes the invention, development and launch of numerous novel surgical implants and sterilization platforms, aseptic formulation and production of biological materials, and quality oversight of manufacturing, validation and testing operations.  Mr. Chang currently serves as Senior Vice President of Business Development at Integra LifeSciences. He is also the  co-founder of Vigilant Bioservices, a biorepository and cold chain logistics services company. Mr. Chang is a member of the Upstate Carolina Angel Network and an Affiliate Faculty Member and External Advisory Board Member at the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida    .